Table 1.
Clinical characteristic | Number of patients (%) |
Median age, years | 38 (range 21–64) |
Sex (n = 15) | |
Female | 6 (40) |
Male | 9 (60) |
History of immunocompromise | 4 (27) |
Sjogren's disease, on intermittent prednisolone, methotrexate | 1 (7) |
Crohn's disease, on chronic mercaptopurine | 1 (7) |
Ulcerative colitis, chronic mercaptopurine, and mesalamine | 2 (13) |
Sites of involvement | |
Bone marrow | 15 (100) |
Splenomegaly | 15 (100) |
Liver involvement | 10 (67) |
Hepatomegaly | 6 (40) |
Biopsy-proven liver involvement in patients without hepatomegaly | 3 (20) |
Abnormal LFTs | 6 (40) |
Adenopathy | 2 (13) |
Peripheral blood involvement | 4 (27) |
B symptoms | |
Fever | 10 (67) |
Night sweats | 9 (60) |
Weight loss | 8 (53) |
Cytopenias | |
Anemia | 8 (73) |
Thrombocytopenia | 7 (64) |
Neutropenia | 4 (36) |
LFTs, liver function tests.